ACQUIREDT+30
Equels Thomas K
Aim Immunotech Inc · NASDAQ
+24,000 sh · $5.0K
Filed 18 Sept 2026SEC Form 4view source
Equels Thomas K
Aim Immunotech Inc · NASDAQ
+24,000 sh · $5.0K
Equels Thomas K
Aim Immunotech Inc · NASDAQ
+11,000 sh · $2.3K
Equels Thomas K
Aim Immunotech Inc · NASDAQ
+22,000 sh · $4.9K
Equels Thomas K
Aim Immunotech Inc · NASDAQ
+5,900 sh · $1.3K
BlackRock
Aim Immunotech Inc · NASDAQ
698,267 sh · $260.2K